A key molecular mechanism drives the growth of liver cell cancer while simultaneously suppressing the body's immune response ...
Liver cancer is one of the three deadliest cancers worldwide, and metabolic dysfunction-related cases have become ...
News Medical on MSN
Engineered liver tissue model mimics early metabolic liver disease
More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD ...
Chronic liver disease gets worse when the liver's immune system stays overactive, resulting in ongoing inflammation and scarring. Signals from the gut make the situation worse by encouraging immune ...
News Medical on MSN
SynGenSys introduces Liver.SET synthetic promoter library for liver-specific gene expression for in vivo gene therapies
SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced ...
Jay N. Yepuri, MD, MS, FACG, is a board-certified gastroenterologist and member of the Digestive Health Associates of Texas Board of Directors and Executive Committee. Liver fibrosis is scarring that ...
Jay N. Yepuri, MD, MS, FACG, is a board-certified gastroenterologist and member of the Digestive Health Associates of Texas Board of Directors and Executive Committee. Silymarin in milk thistle may ...
This episode of Treating Together, hosted by Chandler Park, MD, featuring guests Benjamin Garmezy, MD, and Manoj Bupathi, MD, centers on the intersection of clinical research and community oncology, ...
Fatty liver disease is on the rise among women, often silently progressing until major damage is done. But what causes fatty liver in women specifically? From hormonal shifts to lifestyle choices, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results